Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
| Autor: | Puig, Luis a, ∗, Lebwohl, Mark b, Bachelez, Hervé c, d, Sobell, Jeffrey e, Jacobson, Abby A. f |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology February 2020 82(2):352-359 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect